Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 Sep 22;10(9):e038012.
doi: 10.1136/bmjopen-2020-038012.

Rationale and design of a prospective, observational, multicentre study on the safety and efficacy of apixaban for the prevention of thromboembolism in adults with congenital heart disease and atrial arrhythmias: the PROTECT-AR study

Anastasios Kartas  1 , Ioannis Doundoulakis  1 , Despoina Ntiloudi  1 , Athanasios Koutsakis  1 , Diamantis Kosmidis  1 , Georgios Rampidis  1 , Sotiria Apostolopoulou  2 , Alexandra Frogoudaki  3 , Afrodite Tzifa  4   5 , Dimosthenis Avramidis  4 , Olga Ntzoyvara  2 , Sotiria Liori  3 , Tereza Mousiama  4 , Sophia Anastasia Mouratoglou  1 , Haralambos Karvounis  1 , George Giannakoulas  6
Affiliations
Multicenter Study

Rationale and design of a prospective, observational, multicentre study on the safety and efficacy of apixaban for the prevention of thromboembolism in adults with congenital heart disease and atrial arrhythmias: the PROTECT-AR study

Anastasios Kartas et al. BMJ Open. .

Abstract

Introduction: The risk for stroke in adults with congenital heart disease (ACHD) is increased, especially in the setting of commonly ensuing atrial arrhythmias (AA), namely atrial fibrillation, atrial flutter or intra-atrial re-entrant tachycardia. Data are limited regarding treatment with non-vitamin K oral anticoagulants in long-term studies involving patients with ACHD and AA.

Methods and analysis: PReventiOn of ThromboEmbolism in Adults with Congenital HearΤ disease and Atrial aRrhythmias is a prospective, multicenter, single-arm, non-interventional cohort study designed to investigate the safety and efficacy of apixaban for the prevention of thromboembolism in ACHD with AA in a 'real-world' setting. Eligible patients will be evaluated by the means of available registries and clinical counter. The study aims to accumulate approximately 500 patient-years of exposure to apixaban as part of routine care. Enrolment will take place at four ACHD centres in Greece. The first patient was enrolled in July 2019. The primary efficacy endpoint is a composite of stroke, systemic or pulmonary embolism and intracardiac thrombosis. The primary safety endpoint is major bleeding, according to the International Society on Thrombosis and Haemostasis bleeding criteria.

Ethics and dissemination: The study protocol has been approved by the institutional review board/independent ethics committee at each site prior to study commencement. All patients will provide written informed consent. Results will be disseminated at scientific meetings and published in peer-reviewed journals.

Trial registration number: NCT03854149; Pre-results.

Keywords: anticoagulation; congenital heart disease; epidemiology; protocols & guidelines; stroke; thromboembolism.

PubMed Disclaimer

Conflict of interest statement

Competing interests: GG and HK have received grants and/or personal fees from Pfizer.

Figures

Figure 1
Figure 1
Study plan of the PROTECT-AR study. AA, atrial arrhythmias; ACHD, adults with congenital heart disease; PROTECT-AR, PReventiOn of ThromboEmbolism in Adults with Congenital HearΤ disease and Atrial aRrhythmias.
See this image and copyright information in PMC

References

    1. Hoffmann A, Chockalingam P, Balint OH, et al. Cerebrovascular accidents in adult patients with congenital heart disease. Heart 2010;96:1223–6. 10.1136/hrt.2010.196147 - DOI - PubMed
    1. Bouchardy J, Therrien J, Pilote L, et al. Atrial arrhythmias in adults with congenital heart disease. Circulation 2009;120:1679–86. 10.1161/CIRCULATIONAHA.109.866319 - DOI - PubMed
    1. Lasa JJ, Glatz AC, Daga A, et al. Prevalence of arrhythmias late after the Fontan operation. Am J Cardiol 2014;113:1184–8. 10.1016/j.amjcard.2013.12.025 - DOI - PubMed
    1. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;37:2893–962. 10.1093/eurheartj/ehw210 - DOI - PubMed
    1. Giannakoulas G, Boutsikou M. The Gordian knot of thromboembolism in congenital heart disease. Heart 2015;101:1523–4. 10.1136/heartjnl-2015-308045 - DOI - PubMed

Publication types

Associated data